Passive

Invesco Pharmaceuticals ETF

The Invesco Pharmaceuticals ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical Intellidex® Index (the “Underlying Index”).

$76.35

-0.9% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Pharmaceuticals ETF PJP
Fund Size
$320 Million
Dividend
1.0%
Fees
-
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.4%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.4%
Fees
0.03%
View 1287 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $137 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.43 %
Beta Indicates the relationship between the price performance of a share and the market. 0.5469
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 35.91
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -85.69
Profitable Companies 73
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 807.33
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.27
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 9.21
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 25.49
Enterprise Value to Revenue Enterprise value divided by revenue 69.09
Total Debt to Enterprise Value Total debt divided by enterprise value 0.19
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.4759
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1218.27%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 21.71%
Return on Assets Indicates a company's profitability in relation to its total assets. 4.34%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 9.85%

Industries

Healthcare 86.2%
N/A 13.8%

Market cap

Micro Cap 0%
Small Cap 20%
Mid Cap 21%
Large Cap 29%
Mega Cap 30%

29 Investments

P/E-Ratio
Total Investment
Weight
Invesco Private Prime Fund logo

Invesco Private Prime Fund

P/E-Ratio
n/a
Total Investment
$33.1 Million
Weight
12.1%
AbbVie Inc. logo

ABBV - Manufacturing

AbbVie Inc.

P/E-Ratio
60.5
Total Investment
$17.1 Million
Weight
6.3%
Amgen Inc. logo

AMGN - Manufacturing

Amgen Inc.

P/E-Ratio
21.0
Total Investment
$17.1 Million
Weight
6.2%
Merck & Co., Inc. logo

MRK - Manufacturing

Merck & Co., Inc.

P/E-Ratio
869.1
Total Investment
$17 Million
Weight
6.2%
Abbott Laboratories logo

ABT - Manufacturing

Abbott Laboratories

P/E-Ratio
31.9
Total Investment
$16.1 Million
Weight
5.9%
Eli Lilly and Co. logo

LLY - Manufacturing

Eli Lilly and Co.

P/E-Ratio
135.3
Total Investment
$15.6 Million
Weight
5.7%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
10.0
Total Investment
$15.3 Million
Weight
5.6%
Gilead Sciences, Inc. logo

GILD - Manufacturing

Gilead Sciences, Inc.

P/E-Ratio
14.5
Total Investment
$14.8 Million
Weight
5.4%
Pfizer Inc. logo

PFE - Manufacturing

Pfizer Inc.

P/E-Ratio
67.9
Total Investment
$13 Million
Weight
4.8%
Invesco Private Government Fund logo

Invesco Private Government Fund

P/E-Ratio
n/a
Total Investment
$12.9 Million
Weight
4.7%
Ligand Pharmaceuticals Inc. logo

LGND - Manufacturing

Ligand Pharmaceuticals Inc.

P/E-Ratio
24.6
Total Investment
$10.9 Million
Weight
4.0%
Taro Pharmaceutical Industries Ltd. logo

TARO - Manufacturing

Taro Pharmaceutical Industries Ltd.

P/E-Ratio
0.0
Total Investment
$10.4 Million
Weight
3.8%
Innoviva, Inc. logo

INVA - Manufacturing

Innoviva, Inc.

P/E-Ratio
5.2
Total Investment
$10.3 Million
Weight
3.8%
Pacira BioSciences, Inc. logo

PCRX - Manufacturing

Pacira BioSciences, Inc.

P/E-Ratio
28.9
Total Investment
$10.2 Million
Weight
3.7%
Regeneron Pharmaceuticals, Inc. logo

REGN - Manufacturing

Regeneron Pharmaceuticals, Inc.

P/E-Ratio
24.4
Total Investment
$10.2 Million
Weight
3.7%
Bausch Health Cos. Inc. logo

BHC - Manufacturing

Bausch Health Cos. Inc.

P/E-Ratio
-5.2
Total Investment
$9.64 Million
Weight
3.5%
ANI Pharmaceuticals, Inc. logo

ANIP - Manufacturing

ANI Pharmaceuticals, Inc.

P/E-Ratio
79.0
Total Investment
$9.41 Million
Weight
3.4%
Biogen Inc. logo

BIIB - Manufacturing

Biogen Inc.

P/E-Ratio
23.9
Total Investment
$9.27 Million
Weight
3.4%
Perrigo Co. PLC logo

PRGO - Manufacturing

Perrigo Co. PLC

P/E-Ratio
-319.5
Total Investment
$9.12 Million
Weight
3.3%
Prestige Consumer Healthcare Inc. logo

PBH - Manufacturing

Prestige Consumer Healthcare Inc.

P/E-Ratio
-42.1
Total Investment
$9.04 Million
Weight
3.3%
Jazz Pharmaceuticals PLC logo

JAZZ - Manufacturing

Jazz Pharmaceuticals PLC

P/E-Ratio
16.6
Total Investment
$8.8 Million
Weight
3.2%
Supernus Pharmaceuticals, Inc. logo

SUPN - Manufacturing

Supernus Pharmaceuticals, Inc.

P/E-Ratio
1200.8
Total Investment
$8.77 Million
Weight
3.2%
Amphastar Pharmaceuticals, Inc. logo

AMPH - Manufacturing

Amphastar Pharmaceuticals, Inc.

P/E-Ratio
13.7
Total Investment
$8.15 Million
Weight
3.0%
United Therapeutics Corp. logo

UTHR - Manufacturing

United Therapeutics Corp.

P/E-Ratio
11.3
Total Investment
$8.11 Million
Weight
3.0%
Geron Corp. logo

GERN - Manufacturing

Geron Corp.

P/E-Ratio
-11.1
Total Investment
$7.92 Million
Weight
2.9%